TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Chinese Academy Of Sciences
Curated by ChEMBL
Chinese Academy Of Sciences
Curated by ChEMBL
Affinity DataIC50: 0.0170nMAssay Description:Inhibition of human SHP2 catalytic activity in human MV4-11 cellsMore data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.100nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.100nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.100nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.100nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.100nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.100nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Chinese Academy Of Sciences
Curated by ChEMBL
Chinese Academy Of Sciences
Curated by ChEMBL
Affinity DataIC50: 0.145nMAssay Description:Inhibition of human SHP2 catalytic activity in human MV4-11 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 0.180nMAssay Description:Inhibition of FGFR1 (unknown origin)More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetTyrosine-protein phosphatase non-receptor type 11(Homo sapiens (Human))
Chinese Academy Of Sciences
Curated by ChEMBL
Chinese Academy Of Sciences
Curated by ChEMBL
Affinity DataIC50: 0.202nMAssay Description:Inhibition of human SHP2 catalytic activity in human MV4-11 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 0.230nMAssay Description:Inhibition of FGFR1 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 0.240nMAssay Description:Inhibition of FGFR1 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 0.240nMAssay Description:Inhibition of FGFR1 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 0.25nMAssay Description:Inhibition of FGFR1 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 0.260nMAssay Description:Inhibition of FGFR1 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 0.270nMAssay Description:Inhibition of FGFR1 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 0.280nMAssay Description:Inhibition of FGFR1 (unknown origin)More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.300nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.300nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.300nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.300nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
Affinity DataIC50: 0.320nMAssay Description:Inhibition of FGFR1 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 0.350nMAssay Description:Inhibition of FGFR1 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 0.370nMAssay Description:Inhibition of FGFR1 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 0.370nMAssay Description:Inhibition of FGFR1 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 0.380nMAssay Description:Inhibition of FGFR1 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 0.380nMAssay Description:Inhibition of FGFR1 (unknown origin)More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.400nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.400nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.400nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.400nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-alpha serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.400nMAssay Description:Inhibition of recombinant AKT1 (104 to 480 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptide substrate incubated ...More data for this Ligand-Target Pair
TargetRAC-alpha serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.400nMAssay Description:Inhibition of recombinant AKT1 (104 to 480 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptide substrate incubated ...More data for this Ligand-Target Pair
Affinity DataIC50: 0.420nMAssay Description:Inhibition of FGFR3 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 0.460nMAssay Description:Inhibition of FGFR3 (unknown origin)More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
Affinity DataIC50: 0.5nMAssay Description:Inhibition of CCR2-mediated Erk phosphorylationMore data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair